ADAR1 Capital Management’s Whitehawk Therapeutics WHWK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.04M Hold
1,341,394
– – 0.21% 103
2026
Q2
$6.14M Buy
1,341,394
+1,212,891
+944% +$5.05M 0.28% 81
2026
Q1
$443K Buy
128,503
+50,910
+66% +$159K 0.03% 212
2025
Q4
$188K Buy
+77,593
New +$178K 0.01% 231

Other funds holding WHWK

ADAR1 Capital Management's WHWK Position: Q3 2026 in Review

ADAR1 Capital Management held its Whitehawk Therapeutics (WHWK) position steady in Q3 2026 at 1,341,394 shares worth $5.04M. The position accounts for 0.21% of the portfolio, ranked #103.

ADAR1 Capital Management first reported a position in WHWK in Q4 2025 and has held it in 4 quarters since. The position peaked at $6.14M in Q2 2026. 91 funds tracked by Wall St. Rank hold WHWK as of Q3 2026.

  • ADAR1 Capital Management held 1,341,394 shares of Whitehawk Therapeutics worth $5.04M as of Q3 2026.
  • ADAR1 Capital Management left its Whitehawk Therapeutics share count unchanged in Q3 2026.
  • Whitehawk Therapeutics made up 0.21% of ADAR1 Capital Management's portfolio in Q3 2026, its #103 holding.
  • ADAR1 Capital Management first reported a position in Whitehawk Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • ADAR1 Capital Management's Whitehawk Therapeutics position peaked at $6.14M in Q2 2026.
  • 91 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q3 2026.

Based on ADAR1 Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.